Market Research Reports

Orthobiologics Market (Allografts, Viscosupplements, DBM, BMP, Stem Cell and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

105pages
Published Date: 2013-12-19
 

Description



The global orthobiologics market is largely driven by the rising participation in sports activities and increasing prevalence of arthritis. The research report offers a snapshot of the industry before moving on to a detailed analysis of the various aspects and segments of the market. It discusses the major trends that affect the growth, such as minimally invasive procedures and increasing adoption of bone graft substitutes.

The report is designed to help decision makers understand the nuances of the industry and form strategic business tactics. Offering an unbiased opinion, the study also suggests recommendations for further growth. 

The use of Porter’s five forces analysis, SWOT analysis and value chain analysis, the report breaks the market down into numerous segments, evaluating each and explaining their significance in the market. The competitive landscape is discussed in detail, along with information on company profiles, business overview, financial standing, product portfolio, business strategies, and recent developments. It lays special emphasis on the size and share of the market supplemented with graphs, tables and pie charts. 

The research report promises to build a sound knowledge base to support any research requirement. 

Overview of the orthobiologics market

Orthobiologics refer to substances used by orthopedic surgeons to speed up the process of skeletal and tissue healing. Used to treat orthopedic injuries, orthobiologics combines the body’s inherent ability to heal itself and the use of advanced medical technologies and stem cells to repair and heal injuries. 

The global orthobiologics market was worth $3,745.6 million in 2012and is expected to grow to $5,519.9 million by 2019 at 5.9% CAGR. The main driving force of the market is growing incidences of bone and joint disorders. A large geriatric population and rising interest in sports activities has led to an increase in osteoarthritis and bone injuries respectively. The demand for orthobiologics has also risen due to factors such as expansion of obese population especially in developed nations, change in lifestyle, use of high-tech medical equipment, and the declining popularity of autografts and allografts in orthopedic surgeries. Quick recovery, reduced cost, faster healing and ability to act as an autogenous bone are some of the primary benefits of orthobiologics which has upped its popularity. North America led the global market in 2012 with an estimate value of $1.5 billion.

In contrast, the market growth is likely to be hampered due to reimbursement issues and rigid regulatory requirements. 

Increasing awareness among patients, mounting demand for minimally invasive procedures, rise in disposable income and medical expenditure, and greater prevalence of chronic arthritis are expected to boost the markets in Asia-Pacific. The region is poised to witness the highest CAGR of more than 6.4% in the forecast period of 2013-2019.

Companies mentioned in the market research report

The report profiles some of the leading players of the orthobiologics industry. These include DePuySythes, Stryker Corporation, Orthofix, Inc., Medtronic, Inc., NuVasive, Inc., and Wright Medical Technology, Inc.

This market research report analyzes the following geographies:
  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World 
This report gives you access to decisive data such as:
  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for the coming years 
Key highlights of this report
  • Overview of key market forces propelling and restraining market growth 
  • Up-to-date analyses of market trends and technological improvements in the micro servers industry
  • Pin-point analyses of market competition dynamics to offer you a competitive edge
  • An analysis of strategies of major competitors 
  • An array of graphics and SWOT analysis of major industry segments 
  • Detailed analyses of industry trends
  • A well-defined technological growth map with an impact-analysis 
  • Offers a clear understanding of the competitive landscape and key product segments

Table of Contents



Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
      1.3.1 Assumptions

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Orthobiologics Market (2012 & 2019)
2.2 Global Orthobiologics Market, by Products, 2012 (USD Million)
2.3 Global Orthobiologics Market, by Applications, 2012 (USD Million)

Chapter 3 Market Overview
3.1 Introduction
      3.1.1 Market Drivers
               3.1.1.1 Rising prevalence of chronic arthritis and rapidly aging world population
               3.1.1.2 Surge in sports injuries
               3.1.1.3 Surge in the number of orthopedic surgeries
               3.1.1.4 Technological advances in bone graft materials to boost market growth
               3.1.1.5 Demand for innovative products to bolster the growth of the market
      3.1.2 Restraints
               3.1.2.1 Lack of Reimbursement
               3.1.2.2 Stringent regulatory requirements to restrain market growth
     3.1.3 Opportunities
               3.1.3.1 Rise in cell based matrices
               3.1.3.2 Emerging markets
3.2 Porter’s Five Force Analysis: Global Orthobiologics Market
      3.2.1 Bargaining Power of Suppliers
      3.2.2 Bargaining Power of Buyers
      3.2.3 Threat of New Entrants
      3.2.4 Threat of Substitutes
      3.2.5 Competitive Rivalry
3.3 Market Attractiveness Analysis of the Global Orthobiologics Market, by Geography

Chapter 4 Global Orthobiologics Market, by Product
4.1 Overview
      4.1.1 Global Orthobiologics Market, by Products, 2011 – 2019 (USD Million)
4.2 Bone Morphogenetic Proteins
      4.2.1 Global Bone Morphogenetic Proteins Product Market, 2011 – 2019 (USD Million)
4.3 Demineralized Bone Matrix (DBM)
      4.3.1 Global Demineralized Bone Matrix Product Market, 2011 – 2019 (USD Million)
4.4 Synthetic Bone Substitutes
      4.4.1 Global Synthetic Bone Substitutes Product Market, 2011 – 2019 (USD Million)
4.5 Viscosupplementation
      4.5.1 Global Viscosupplementation Product Market, 2011 – 2019 (USD Million)
4.6 Allograft
      4.6.1 Global Allografts Product Market, 2011 – 2019 (USD Million)
4.7 Stem Cell Therapy
      4.7.1 Global Stem Cell Therapy Product Market, 2011 – 2019 (USD Million)
4.8 Machined Bones
      4.8.1 Global Machined Bones Product Market, 2011 – 2019 (USD Million)

Chapter 5 Global Orthobiologics Market, by Application
5.1 Overview
      5.1.1 Global Orthobiologics Market, by Applications, 2011 – 2019 (USD Million)
5.2 Spinal Fusion
      5.2.1 Global Spinal Fusion Application Market, 2011 – 2019 (USD Million)
5.3 Trauma
      5.3.1 Global Trauma Application Market, 2011 – 2019 (USD Million)
5.4 Reconstructive surgery
      5.4.1 Global Reconstructive Surgery Application Market, 2011 – 2019 (USD Million)

Chapter 6 Global Orthobiologics Market, by Geography
6.1 Overview
      6.1.1 Global Orthobiologics Market, by Geography, 2011 – 2019 (USD Million)
6.2 Comparative Analysis: Orthobiologics Market, by Geography, 2012 & 2019 (Value %)
6.3 North America
      6.3.1 North America Orthobiologics Market, by Product, 2011 – 2019 (USD Million)
      6.3.2 North America Orthobiologics Market, by Application, 2011 – 2019 (USD Million)
6.4 Europe
      6.4.1 Europe Orthobiologics Market, by Product, 2011 – 2019 (USD Million)
      6.4.2 Europe Orthobiologics Market, by Application, 2011 – 2019 (USD Million)
6.5 Asia-Pacific
      6.5.1 Asia-Pacific Orthobiologics Market, by Product, 2011 – 2019 (USD Million)
      6.5.2 Asia-Pacific Orthobiologics Market, by Application, 2011 – 2019 (USD Million)
6.6 RoW
      6.6.1 RoW Orthobiologics Market, by Product, 2011 – 2019 (USD Million)
      6.6.2 RoW Orthobiologics Market, by Application, 2011 – 2019 (USD Million)

Chapter 7 Global Orthobiologics Market Share Analysis
7.1 Market Share Analysis by Key Players of Global Orthobiologics Market
      7.1.1 Global Orthobiologics Market Share Analysis, by Key Players, 2012 (%)

Chapter 8 Recommendations
8.1 Success strategies
      8.1.1 Rigorous research and development (R&D) initiatives
      8.1.2 Investing in emerging economies
8.2 Barriers to be considered
      8.2.1 Significant Cost of Investment

Chapter 9 Company Profiles
9.1 Alphatec Spine, Inc.
      9.1.1 Business Overview
      9.1.2 Financial Overview
      9.1.3 Product Portfolio
      9.1.4 Business Strategies
      9.1.5 Recent Developments
9.2 Bacterin International, Inc.
      9.2.1 Business Overview
      9.2.2 Financial Overview
      9.2.3 Product Portfolio
      9.2.4 Business Strategies
      9.2.5 Recent Developments
9.3 Biomet, Inc.
      9.3.1 Business overview
      9.3.2 Financial Overview
      9.3.3 Product Portfolio
      9.3.4 Business Strategies
9.4 DePuy Synthes, Inc. (A Johnson & Johnson Company)
      9.4.1 Business Overview
      9.4.2 Financial Overview
      9.4.3 Product Portfolio
      9.4.4 Business Strategies
      9.4.5 Recent Developments
9.5 Exactech, Inc.
      9.5.1 Business Overview
      9.5.2 Financial Overview
      9.5.3 Product Portfolio
      9.5.4 Business Strategies
      9.5.5 Recent Developments
9.6 Globus Medical, Inc.
      9.6.1 Business Overview
      9.6.2 Financial Overview
      9.6.3 Product Portfolio
      9.6.4 Business Strategies
      9.6.5 Recent Developments
9.7 Integra LifeSciences Corporation
      9.7.1 Business Overview
      9.7.2 Financial Overview
      9.7.3 Product Portfolio
      9.7.4 Business Strategies
      9.7.5 Recent Developments
9.8 Medtronic, Inc.
      9.8.1 Business Overview
      9.8.2 Financial Overview
      9.8.3 Product Portfolio
      9.8.4 Business Strategies
      9.8.5 Recent Developments
9.9 NuVasive, Inc.
      9.9.1 Business Overview
      9.9.2 Financial Overview
      9.9.3 Product Portfolio
      9.9.4 Business Strategies
      9.9.5 Recent Developments
9.10 Orthofix Holdings, Inc.
      9.10.1 Business Overview
      9.10.2 Financial Overview
      9.10.3 Products Portfolio
      9.10.4 Business Strategies
      9.10.5 Recent Developments
9.11 Regeneration Technologies, Inc.
      9.11.1 Business Overview
      9.11.2 Financial Overview
      9.11.3 Product Portfolio
      9.11.4 Business Strategies
      9.11.5 Recent Developments
9.12 Sanofi
      9.12.1 Business Overview
      9.12.2 Financial Overview
      9.12.3 Product Portfolio
      9.12.4 Business Strategies
      9.12.5 Recent Developments
9.13 Stryker Corporation
      9.13.1 Business Overview
      9.13.2 Financial Overview
      9.13.3 Product Portfolio
      9.13.4 Business Strategies
      9.13.5 Recent Developments
9.14 Wright Medical Technology, Inc.
      9.14.1 Business Overview
      9.14.2 Financial Overview
      9.14.3 Product Portfolio
      9.14.4 Business Strategies
      9.14.5 Recent Developments
9.15 Zimmer Holdings, Inc.
      9.15.1 Business Overview
      9.15.2 Financial Overview
      9.15.3 Product Portfolio
      9.15.4 Business Strategies
      9.15.5 Recent Developments

List of Figures

FIG. 1 Orthobiologics: Market Segmentation
FIG. 2 Global Orthobiologics Market, by Products, 2012 (USD Million)
FIG. 3 Global Orthobiologics Market, by Application, 2012 (USD Million)
FIG. 4 Porter’s Five Force Analysis: Global Orthobiologics Market
FIG. 5 Market Attractiveness Analysis: Global Orthobiologics Market, by Geography
FIG. 6 Global Bone Morphogenetic Protein Products, 2011 – 2019 (USD Million)
FIG. 7 Global Demineralized Bone Matrix Products, 2011 – 2019 (USD Million)
FIG. 8 Global Synthetic Bone Substitute Products, 2011 – 2019 (USD Million)
FIG. 9 Global Viscosupplementation Products, 2011 – 2019 (USD Million)
FIG. 10 Global Allograft Products, 2011 – 2019 (USD Million)
FIG. 11 Global Stem Cell Therapy Products, 2011 – 2019 (USD Million)
FIG. 12 Global Machined Bone Products, 2011 – 2019 (USD Million)
FIG. 13 Global Spinal Fusion Application Market, 2011 – 2019 (USD Million)
FIG. 14 Global Trauma Application Market, 2011 – 2019 (USD Million)
FIG. 15 Global Reconstructive Surgery Application Market, 2011 – 2019 (USD Million)
FIG. 16 Comparative Analysis: Orthobiologics Market, by Geography, 2012 & 2019 (Value %)
FIG. 17 Global Orthobiologics: Market Share, by Key Players, 2012 (%)
FIG. 18 Alphatec Spine, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 19 Bacterin International Holdings, Inc., Annual Revenue: 2010– 2012 (USD Million)
FIG. 20 Biomet, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 21 Johnson & Johnson, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 22 Exactech, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 23 Globus Medical, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 24 Integra LifeSciences Corporation, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 25 Medtronic, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 26 NuVasive, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 27 Orthofix Holdings, Inc., Annual Revenue: 2010-2012 (USD Million)
FIG. 28 Regeneration Technologies, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 29 Sanofi, Annual Revenue: 2010 – 2012 (USD Million) (1 Euro= 1.31 USD)
FIG. 30 Stryker Corporation, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 31 Wright Medical Technology, Inc.: Annual Revenue 2010 – 2012 (USD Million)
FIG. 32 Zimmer Holdings. Inc, Annual Revenue: 2010 – 2012 (USD Million)

List of Tables

TABLE 1 Market Snapshot: Global Orthobiologics Market (2012 & 2019)
TABLE 2 Global Orthobiologics Market, by Products, 2011 – 2019 (USD Million)
TABLE 3 Global Orthobiologics Market, by Applications, 2011 – 2019 (USD Million)
TABLE 4 Global Orthobiologics Market, by Geography, 2011 – 2019 (USD Million)
TABLE 5 North America Orthobiologics Market, by Products, 2011 – 2019 (USD Million)
TABLE 6 North America Orthobiologics Market, by Applications, 2011 – 2019 (USD Million)
TABLE 7 Europe Orthobiologics Market, by Products, 2011 – 2019 (USD Million)
TABLE 8 Europe Orthobiologics Market, by Applications, 2011 – 2019 (USD Million)
TABLE 9 Asia-Pacific Orthobiologics Market, by Products, 2011 – 2019 (USD Million)
TABLE 10 Asia-Pacific Orthobiologics Market, by Applications, 2011 – 2019 (USD Million)
TABLE 11 RoW Orthobiologics Market, by Products, 2011 – 2019 (USD Million)
TABLE 12 RoW Orthobiologics Market, by Applications, 2011 – 2019 (USD Million)

Enquiry Before Buying


Free Market Analysis


Orthobiology is a branch of science that develops bone and tissue replacement materials for fasthealing and quick recovery of injured muscles, broken bones, ligaments and tendons. Orthobiologics is considered as a highly lucrative market owing to significant growth opportunities. One of the major driver for the growth of this industry is certain limitations that are associated with autografts and allografts. Although, autografts are considered as gold standard for orthopedic procedures but the usage of autograft involves donor site morbidity and an additional surgery. While, the major concerns associated with allografts is risk of disease transmission along with the decline in theiravailability. Therefore, in order to overcome these drawbacks of the autografts and allografts, bone graft substitutes are being preferred for use in orthopaedic surgery. 

According to the American Academy of Orthopedic Surgeons (AAOS), approximately 465,000 spinal surgeries were performed in the U.S in 2011. Of all the spinal fusion surgeries performed, 46% were for lumbar fusion, 42% were for cervical fusion and the remaining 13% were for thoracic or multi-level fusion procedures. This rise in number of spinal fusion surgeries has created the demand for bone graft substitutes and has consequently boosted the overall growth of this industry. In addition, rise in the incidence of arthritis, increase in geriatric population and increase in obesity rate has triggered the growth of this market. Technological advancements, growing demand for minimally invasive procedures and rising patient awareness are the other factors that has considerably augmented the growth of this market. The global orthobiologics market was valued at USD 3,754.6 million in 2012 and is expected to grow at a CAGR of 5.9%from 2013 to 2019 to reach at an estimated value of USD 5,519.9 million in 2019.

At present, viscosupplementation accounts for the largest share of the orthobiologics market. The growth in this market is attributed to growing popularity of knee treatments and its ability to act as an effective pain killer as compared to NSAIDS and others. This market is followed by bone morphogenetic proteins (BMPs) which is characterized by its ability to provide faster recovery, lesser pain and ability to stimulate patients own cells for regeneration. However, the market is expected to show a negative growth rateduring the forecast period due to decline in the sales of “INFUSE” a Medtronic product. Severe side effects associated with INFUSE due to its heavy off label usage led to recall of this product by the U.S FDA. Synthetic bone substitutes and stem cell based products are expected to witness a significant growth during the forecast period. The growth of these segments is witnessed due to reduced cost, quick recovery and eliminated risk of disease transmission. 

Geographically, North America and Europe dominates the orthobiologics market. The dominance in these region is witnessed due to rise in incidence of arthritis and higher obesity rates that has surged the demand for minimally invasive procedures such as bone grafting and growth factor treatment. These treatments offer enhanced well-being and durability, with minimal side effects while eliminating the need for repeated hospital visits. However, the Asia-Pacific region is expected to show highest growth rate during the forecast period. The demand for orthobiologics in this region is witnessed due to increase in number of orthopedic disease due to change in lifestyle, change in diet which all lead to increasing obesity rate and consequently leads to arthritis and other bone disorders. Moreover, rise in geriatric population and increase in sports related injuries are other factors likely to drive the growth of orthobiologics in this region.

The major players engaged in the orthobiologics market include Medtronic, Inc., DePuySynthes, Wright Medical Technology, Inc., Stryker Corporation, Orthofix, Inc., NuVasive, Inc., and other significant players.

global-orthobiologics-market-by-products-2012
 

To get discount on this report, just click on the button below.

To receive brochure, please click on the button below.

Share This Market Study!  

Upcoming Report

Payment
Copyright @ Transparency Market Research